303 related articles for article (PubMed ID: 30113683)
41. Post-saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism.
Weigel M; Riester A; Hanslik G; Lang K; Willenberg HS; Endres S; Allolio B; Beuschlein F; Reincke M; Quinkler M
Eur J Endocrinol; 2015 Apr; 172(4):443-50. PubMed ID: 25630564
[TBL] [Abstract][Full Text] [Related]
42. The role of adrenal venous sampling in the surgical management of primary aldosteronism.
Toniato A; Bernante P; Rossi GP; Pelizzo MR
World J Surg; 2006 Apr; 30(4):624-7. PubMed ID: 16568223
[TBL] [Abstract][Full Text] [Related]
43. Effect of Treatment on Body Fluid in Patients with Unilateral Aldosterone Producing Adenoma: Adrenalectomy versus Spironolactone.
Wu CH; Yang YW; Hung SC; Tsai YC; Hu YH; Lin YH; Chu TS; Wu KD; Wu VC
Sci Rep; 2015 Oct; 5():15297. PubMed ID: 26477337
[TBL] [Abstract][Full Text] [Related]
44. Secondary hypertension due to concomitant aldosterone-producing adenoma and parathyroid adenoma.
Chau K; Holmes D; Melck A; Chan-Yan C
Am J Hypertens; 2015 Feb; 28(2):280-2. PubMed ID: 24951725
[TBL] [Abstract][Full Text] [Related]
45. Malignant hypertension in a patient with primary aldosteronism with elevated active renin concentration.
Oka K; Hayashi K; Nakazato T; Suzawa T; Fujiwara K; Saruta T
Intern Med; 1997 Oct; 36(10):700-4. PubMed ID: 9372330
[TBL] [Abstract][Full Text] [Related]
46. Role of aldosterone in left ventricular hypertrophy in hypertension.
Matsumura K; Fujii K; Oniki H; Oka M; Iida M
Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
[TBL] [Abstract][Full Text] [Related]
47. Recent advances in diagnosis and treatment of primary aldosteronism.
Veglio F; Morello F; Rabbia F; Leotta G; Mulatero P
Minerva Med; 2003 Aug; 94(4):259-65. PubMed ID: 14605590
[TBL] [Abstract][Full Text] [Related]
48. The association of serum potassium level with left ventricular mass in patients with primary aldosteronism.
Lin YH; Wang SM; Wu VC; Lee JK; Kuo CC; Yen RF; Liu KL; Huang KH; Chueh SC; Wang WJ; Lin LY; Chien KL; Ho YL; Chen MF; Wu KD;
Eur J Clin Invest; 2011 Jul; 41(7):743-50. PubMed ID: 21250985
[TBL] [Abstract][Full Text] [Related]
49. KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism.
Rossi GP; Cesari M; Letizia C; Seccia TM; Cicala MV; Zinnamosca L; Kuppusamy M; Mareso S; Sciomer S; Iacobone M; Mantero F; Pessina AC
J Hypertens; 2014 Jul; 32(7):1514-21; discussion 1522. PubMed ID: 24759126
[TBL] [Abstract][Full Text] [Related]
50. Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism.
Lin YH; Wu XM; Lee HH; Lee JK; Liu YC; Chang HW; Lin CY; Wu VC; Chueh SC; Lin LC; Lo MT; Ho YL; Wu KD;
J Hypertens; 2012 Aug; 30(8):1606-13. PubMed ID: 22688266
[TBL] [Abstract][Full Text] [Related]
51. Defining contralateral adrenal suppression in primary aldosteronism: implications for diagnosis and outcome.
Kline GA; Chin A; So B; Harvey A; Pasieka JL
Clin Endocrinol (Oxf); 2015 Jul; 83(1):20-7. PubMed ID: 25400021
[TBL] [Abstract][Full Text] [Related]
52. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Rossi GP; Bernini G; Caliumi C; Desideri G; Fabris B; Ferri C; Ganzaroli C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Mattarello MJ; Moretti A; Palumbo G; Parenti G; Porteri E; Semplicini A; Rizzoni D; Rossi E; Boscaro M; Pessina AC; Mantero F;
J Am Coll Cardiol; 2006 Dec; 48(11):2293-300. PubMed ID: 17161262
[TBL] [Abstract][Full Text] [Related]
53. Conn's syndrome (primary hyperaldosteronism) simulating polymyositis.
Kaşifoğlu T; Korkmaz C; Paşaoğlu O
Rheumatol Int; 2005 Mar; 25(2):133-4. PubMed ID: 15034751
[TBL] [Abstract][Full Text] [Related]
54. Diagnosis and management of primary aldosteronism: an updated review.
Chao CT; Wu VC; Kuo CC; Lin YH; Chang CC; Chueh SJ; Wu KD; Pimenta E; Stowasser M
Ann Med; 2013 Jun; 45(4):375-83. PubMed ID: 23701121
[TBL] [Abstract][Full Text] [Related]
55. Surgery decreases the long-term incident stroke risk in patients with primary aldosteronism.
Chang YH; Chung SD; Wu CH; Chueh JS; Chen L; Lin PC; Lin YH; Huang KH; Wu VC; Chu TS;
Surgery; 2020 Feb; 167(2):367-377. PubMed ID: 31676114
[TBL] [Abstract][Full Text] [Related]
56. Dietary Salt Intake Is a Determinant of Cardiac Changes After Treatment of Primary Aldosteronism: A Prospective Study.
Catena C; Colussi G; Novello M; Verheyen ND; Bertin N; Pilz S; Tomaschitz A; Sechi LA
Hypertension; 2016 Jul; 68(1):204-12. PubMed ID: 27245179
[TBL] [Abstract][Full Text] [Related]
57. Combined Conn's and Cushing's syndrome: an unusual presentation of adrenal adenoma.
Baert D; Nobels F; Van Crombrugge P
Acta Clin Belg; 1995; 50(5):310-3. PubMed ID: 8533534
[TBL] [Abstract][Full Text] [Related]
58. Predictive factors of left ventricular mass changes after treatment of primary aldosteronism.
Catena C; Colussi GL; Marzano L; Sechi LA
Horm Metab Res; 2012 Mar; 44(3):188-93. PubMed ID: 22351477
[TBL] [Abstract][Full Text] [Related]
59. The Impact of Glucocorticoid Co-Secretion in Primary Aldosteronism on Thyroid Autoantibody Titers During the Course of Disease.
Handgriff L; Adolf C; Heinrich DA; Braun L; Nirschl N; Sturm L; Ladurner R; Ricke J; Seidensticker M; Bidlingmaier M; Reincke M
Horm Metab Res; 2020 Jun; 52(6):404-411. PubMed ID: 32403151
[TBL] [Abstract][Full Text] [Related]
60. Primary aldosteronism with aldosterone-producing adrenal adenoma in a pregnant woman.
Fujiyama S; Mori Y; Matsubara H; Okada S; Maruyama K; Masaki H; Yonemoto T; Nagata T; Umeda Y; Matsuda T; Iwasaka T; Inada M
Intern Med; 1999 Jan; 38(1):36-9. PubMed ID: 10052740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
